Chemed (NYSE:CHE) Issues Quarterly Earnings Results

Chemed (NYSE:CHE) announced its earnings results on Tuesday. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12), Briefing.com reports. The business had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $5.32 EPS. Chemed updated its FY24 guidance to $23.00-$23.15 EPS and its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Stock Down 0.9 %

CHE traded down $4.92 during trading hours on Friday, reaching $535.32. 128,505 shares of the company’s stock traded hands, compared to its average volume of 84,868. The firm has a 50-day moving average price of $586.09 and a 200 day moving average price of $568.84. The firm has a market capitalization of $8.06 billion, a PE ratio of 27.32, a PEG ratio of 2.18 and a beta of 0.44. Chemed has a 52-week low of $525.36 and a 52-week high of $654.62.

Insiders Place Their Bets

In related news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares in the company, valued at $1,819,893.62. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,144 shares of company stock worth $4,141,679 over the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.